PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 30 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $8,000 | +33.3% | 20,300 | -2.4% | 0.00% | – |
| Q4 2018 | $6,000 | +500.0% | 20,800 | +824.4% | 0.00% | – |
| Q3 2018 | $1,000 | – | 2,250 | +350.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 500 | -97.4% | 0.00% | – |
| Q1 2018 | $10,000 | +42.9% | 19,100 | +76.9% | 0.00% | – |
| Q4 2017 | $7,000 | -30.0% | 10,800 | -38.3% | 0.00% | – |
| Q3 2017 | $10,000 | -33.3% | 17,500 | -2.8% | 0.00% | -100.0% |
| Q2 2017 | $15,000 | -91.4% | 18,000 | -86.0% | 0.00% | -87.5% |
| Q1 2017 | $174,000 | +5700.0% | 128,440 | +2187.9% | 0.01% | – |
| Q3 2016 | $3,000 | – | 5,614 | +4391.2% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 125 | -98.4% | 0.00% | -100.0% |
| Q2 2015 | $15,000 | -64.3% | 7,848 | -67.2% | 0.00% | -80.0% |
| Q1 2015 | $42,000 | +2000.0% | 23,900 | +1673.0% | 0.01% | – |
| Q4 2014 | $2,000 | – | 1,348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,825,000 | $1,206,000 | 0.39% |
| Zhang Financial LLC | 45,000 | $33,000 | 0.02% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 472,553 | $313,000 | 0.01% |
| MEITAV INVESTMENT HOUSE LTD | 127,062 | $85,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 324,479 | $215,000,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 302,588 | $200,000 | 0.00% |
| Renaissance Technologies | 1,993,500 | $1,318,000 | 0.00% |
| WEDBUSH SECURITIES INC | 15,000 | $10,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 57,127 | $38,000 | 0.00% |
| Psagot Value Holdings Ltd. | 29,193 | $20,000 | 0.00% |